| 发明名称 |
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF |
| 摘要 |
The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus. |
| 申请公布号 |
US2016038525(A1) |
申请公布日期 |
2016.02.11 |
| 申请号 |
US201514918818 |
申请日期 |
2015.10.21 |
| 申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
BROEDL Uli Christian;JOHANSEN Odd-Erik;MAYOUX Eric Williams;SOLEYMANLOU Nima;von EYNATTEN Maximilian;WOERLE Hans-Juergen;CHERNEY David Z.I.;PERKINS Bruce A. |
| 分类号 |
A61K31/7048;A61K45/06 |
主分类号 |
A61K31/7048 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1) A method of treating, preventing, protecting against, reducing the risk of, delaying the occurrence of and/or delaying the progression of chronic kidney disease in a patient, said method comprising administering empagliflozin, optionally in combination with one or more other therapeutic substances, to the patient. |
| 地址 |
Ingelheim am Rhein DE |
